Trial Site Detail
Drug: |
CB-839 |
|||
|---|---|---|---|---|
Trial: |
Study of the Glutaminase Inhibitor CB-839 in Solid Tumors |
|||
| Conditions: | Solid Tumors | |||
Trial Status: |
Active, not recruiting |
|||
UCSF Helen Diller Family Comprehensive Cancer Center1450 3rd St. |
Principal Investigator: |
Pamela Munster |
|---|---|
Contact: |
Ilaria Mastroserio 415-514-6245 Ilaria.Mastroserio@ucsf.edu |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
UCSF Helen Diller Family Comprehensive Cancer Center Website: |
https://clinicaltrials.ucsf.edu/ |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.